 |
Terry McGuire is a co-founder and general partner of Polaris Partners based in the Boston office. McGuire focuses on life sciences investments.
|
Terry McGuire is a co-founder and general partner of Polaris Partners based in the Boston office. McGuire focuses on life sciences investments.
Prior to starting Polaris, McGuire spent seven years as a partner at the venture capital firm Burr, Egan, Deleage & Co. investing in early-stage medical and information technology companies. McGuire was also a partner at Beta Partners from 1988 to 1997. His venture capital career began at Golder, Thoma & Cressey in Chicago.
Through the years, McGuire has invested in a multitude of companies spanning several industries. These investments include Akamai, Aspect Medical Systems, Cubist Pharmaceuticals, GlycoFi, Transform Pharmaceuticals, and Remon Medical Technologies. Akamai is an internet service that deals with Web interactions, and works to improve effective connections. Today, Akamai is a public company. Another example is GlycoFi, which creates biotherapeutics through proteins. GlycoFi was acquired by Merck in 2006.
McGuire has co-founded three companies: Inspire Pharmaceuticals, AIR (Advanced Inhalation Research, Inc.), and MicroCHIPS. AIR has created a drug delivery method that allows drugs to be inhaled into the lungs.
Companies Terry has supported have touched more than 60 million patients and directly saved over 400,000 lives. These companies have raised over $6 billion in equity and corporate capital. As a group, they have achieved a combined peak enterprise value of over $40 billion.
McGuire is currently a member and formerly the 2009 - 2010 chairman of the National Venture Capital Association, the largest organization of venture capital firms in the United States. [1] During his tenure as NVCA Chairman, in October 2009, McGuire testified before Congress for Dodd-Frank Wall Street Reform and Consumer Protection Act. In 2010, McGuire founded the Global Venture Capital Congress which is an annual gathering of venture capital and private equity leaders dedicated to actively supporting the world's venture capital and entrepreneurial economy through the sharing of common issues and ideas, the discussion of regional differences and opportunities for collaboration, and the communication of best practices on a global basis. McGuire is also the Chair of the board of overseers at the Thayer School of Engineering at Dartmouth College. [2] He also serves on the boards of MIT’s David H. Koch Institute for Integrative Cancer Research, The Arthur Rock Center for Entrepreneurship, and the Healthcare Initiative Advisory Board.
McGuire also represents Polaris on the boards of directors of a number of the firm's portfolio companies including Acceleron Pharma, [3] AdiMAB, Arsenal Medical, Ironwood Pharmaceuticals, Iora Health, Life Line Screening, MicroCHIPS, Pulmatrix, SustainX and Trevena.
In 2005, McGuire received the Albert Einstein Award for Outstanding Achievement in the Life Sciences. In 2009, he was the recipient of the Massachusetts Society for Medical Research Award. He was listed in Forbes - The Midas 100 of Top Tech Investors for 2011, [4] the 2013 Top 10 Life Sciences Investors, [5] and again to the Midas 100 list in 2014. [6] TheFunded ranked McGuire its most loved VC. [7]
McGuire received an MBA from Harvard Business School in 1985. Prior to that, he earned his MS in engineering from the Thayer School of Engineering at Dartmouth College. He became a Thomas J. Watson fellow in 1979. McGuire earned his BS in physics and economics from Hobart College.
In 2012 Terry was awarded an honorary Doctorate of Laws degree from Ohio Wesleyan University for his work in translational science. In 2016, McGuire received an honorary Doctorate of Humane Letters from Canisius College, serving as the commencement speaker the same year.
Stephen T. Jurvetson is an American billionaire businessman and venture capitalist. Formerly a partner of the firm Draper Fisher Jurvetson (DFJ), he was an early investor in Hotmail, Memphis Meats, Mythic and Nervana Systems. He is currently a board member of SpaceX among others. He later co-founded the firm Future Ventures with Maryanna Saenko, who worked with him at DFJ.
Peter Barris is an American businessman and venture capitalist. He is a founding Venture Capital Investor in Groupon.
David Frankel is a South African-born American entrepreneur and venture capitalist. He is the co-founder of Founder Collective, a seed-stage venture capital fund with offices in New York City and Cambridge.
Tillman Gerngross is an Austro-American scientist.
Burr, Egan, Deleage & Co. (BEDCO) was a venture capital firm which focused on investments in information technology, communications, and healthcare/biotechnology companies.
Polaris Partners is a venture capital firm active in the field of healthcare and biotechnology companies. The company has offices in Boston, Massachusetts, New York, NY and San Francisco, California.
Corporate venture capital (CVC) is the investment of corporate funds directly in external startup companies. CVC is defined by the Business Dictionary as the "practice where a large firm takes an equity stake in a small but innovative or specialist firm, to which it may also provide management and marketing expertise; the objective is to gain a specific competitive advantage." Examples of CVCs include GV and Intel Capital.
James W. Breyer is an American venture capitalist, founder and chief executive officer of Breyer Capital, an investment and venture philanthropy firm, and a former managing partner at Accel Partners, a venture capital firm. Breyer has invested in over 40 companies that have gone public or completed a merger, with some of these investments, including Facebook, earning over 100 times cost and many others over 25 times cost. On the Forbes 2021 list of the 400 richest Americans, he was ranked #389, with a net worth of US$2.9 billion.
Christoph Westphal is an American biomedical businessman.
Jonathan A. Flint is a venture capitalist and entrepreneur who co-founded venture capital firms Polaris Partners and Polaris Founders Capital, as well as the companies Living Proof and Icelandic Provisions.
Arie S. Belldegrun, FACS, is an Israeli-American urologic oncologist, billionaire businessman and investor.
Boston Millennia Partners is a venture capital firm that provides private equity financing to high growth companies in the healthcare and business services industries. The firm is based in Boston, Massachusetts and was formed in 1997 when the founding partners spun out of Boston Capital Ventures to create Boston Millennia Partners. The managers have organized nine separate investment partnerships. Boston Millennia Partners’ investors include institutions, corporate pension programs, as well as non-profit foundations and high-net-worth family offices.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
Aileen Lee is a U.S. venture capital angel investor and co-founder of Cowboy Ventures.
Josh Stein is an American businessman and venture capitalist. He is a managing partner at Threshold Ventures and was featured in the Forbes Midas List in 2013, 2014 and 2015 in recognition of his accomplishments as an investor. He was also the recipient of the 2015 Deloitte Fast 500 Venture Capitalist of the Year award. Stein holds board responsibilities at Box (company), Chartbeat, LaunchDarkley, LendKey, Lumity, and Talkdesk—and led Box’s first round of institutional investment. He is also an investor in AngelList, Doximity, Front, Loftium, Periscope Data acquired by Sisense, and Rippling.
Initialized Capital is a venture capital fund founded in 2011 and headquartered in San Francisco. It was founded by Alexis Ohanian, Harjeet Taggar, and Garry Tan.
Foresite Capital (Foresite) is an American, multi-stage healthcare and life sciences investment firm headquartered in Los Angeles, and with offices in The San Francisco Bay Area and New York City. As of June 2024, the company had raised six primary funds: Foresite Capital Fund I, II, III, IV, V and VI.
Pejman Nozad is an Iranian-American venture capitalist known for co-founding Pear VC and Amidzad Partners. He is also a former radio host and professional soccer player. He was ranked in the 15th spot in Forbes' annual Midas List in 2021 and also 2022. He was #1 on the seed investors list in 2024.
Nisa Leung is a venture capitalist and managing partner at Qiming Venture Partners. She has been named on the Forbes Midas List for six consecutive years since 2019. and ranked top 2 in Best Women Venture Capitalists by Forbes China for three successive years since 2021. She was awarded The Fortune Most Powerful Women Asia in 2024 by Fortune Asia and The Most Powerful Women in Business by Fortune China from 2022 to 2024. Nisa is widely known as China's leading investor in healthcare.